Author

Jules B. Weinstein

Oregon Health & Science UniversityORCID 0000-0002-2983-3386Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

Fikadu G. TafesseiD· 3 shared John E. BurkeiD· 3 shared Aidan AnastasiD· 2 shared Audrey HinchliffiD· 2 shared Mila Trank-GreeneiD· 2 shared Sintayehu Kebede GurmessaiD· 2 shared Timothy A. BatesiD· 2 shared Ayna Alfahdli· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Fikadu G. TafesseORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies

Jules B. Weinstein, Timothy A. Bates, Aidan Anastas, Ayna Alfahdli, Mila Trank-Greene, Savannah K. McBride, Michelle Garcia, Matthew AH Parson, Meredith L. Jenkins, John E. Burke, Eric Barklis, Fikadu Tafesse

This study develops domain-specific nanobodies that inhibit SARS-CoV-2 infection by disrupting N protein phase separation and replication.

bioRxiv · Jan 27, 2026 · PreprintMicrobiology

Selective inhibition of MR1-restricted T cell activation by a novel MR1-targeting nanobody

Timothy Bates, Corinna A. Kulicke, Sintayehu Kebede Gurmessa, Se-Jin Kim, Sushant Suresh, Jules B. Weinstein, Audrey Hinchliff, John E. Burke, David Michael Lewinsohn, Fikadu Tafesse

This study develops a high-affinity anti-MR1 nanobody that selectively inhibits MR1-restricted T cell activation, providing insights into MR1 function and a tool for immunological research.

bioRxiv · Jun 11, 2025 · PreprintImmunology

An effective method of measuring nanobody binding kinetics and competition-based epitope mapping using biolayer interferometry

Timothy A. Bates, Sintayehu Kebede Gurmessa, J. B. Reyes-Weinstein, Mila Trank-Greene, Xammy Huu Nguyenla, Aidan Anastas, Teketay Wassie Anley, Audrey Hinchliff, Ujwal P. Shinde, John E. Burke, Fikadu G. Tafesse

The paper describes a method using biolayer interferometry to measure nanobody binding kinetics and perform competition-based epitope mapping.

Nature Protocols · Nov 21, 2024Peer-reviewedBiochemistry